Chemical Properties:
Package: Bottle, Barrel, 25kg/Barrel, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer Supply Argatroban Related Intermediates: Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Monohydrate CAS 141396-28-3 Argatroban Anhydrous CAS 74863-84-6| Item | Specifications |
| Appearance | Clear to Light Yellow Liquid |
| Diastereoisomer | ≤1.0% |
| Purity / Analysis Method | ≥98.0% (GC) |
| Heavy Metals | ≤20ppm |
| Test Standard | Enterprise Standard |
| Usage | Argatroban Intermediate (CAS 74863-84-6) |
Description:
Specifications:
Package & Storage:
| Chemical Name | Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
| Synonyms | Ethyl (2R,4R)-4-Methylpipecolate; (2R,4R)-4-Methyl-2-Piperidinecarboxylate; (2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate; Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
| CAS Number | 74892-82-3 |
| CAT Number | RF-PI267 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H17NO2 |
| Molecular Weight | 171.24 |
| Shipping Condition | Shipped Under Ambient Temperature |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) with high quality. Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) is an intermediate typically in the synthesis of Argatroban Monohydrate (CAS 141396-28-3) or Argatroban (CAS 74863-84-6). Argatroban Monohydrate is a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi. Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT).
